However, since HRT has short-term effects and is associated with an increased risk of various conditions (e.g., osteoporosis, breast cancer and cardiovascular) [16,17], phosphatase and tensin homolog (PTEN) inhibitors and therapies based on stem cells have been studied to overcome the limitations of HRT. This evidence concerns the gene PTEN and breast carcinoma.